The grades of five health care provider stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an “A” (“strong buy”) or “B” overall (“buy”) rating.
Cross Country Healthcare, Inc. (CCRN) is bettering its rating of C (“hold”) from last week to a B (“buy”) this week. Cross Country Healthcare provides healthcare staffing and outsourcing services to the healthcare market. In Portfolio Grader’s specific subcategories of Earnings Momentum, Earnings Surprise and Sales Growth, CCRN also gets A’s. For more information, get Portfolio Grader’s complete analysis of CCRN stock.
Triple-S Management Corporation Class B (GTS) is seeing ratings go up from an A last week to a C this week. Triple-S Management is an independent licensee of the Blue Cross Blue Shield Association. For more information, get Portfolio Grader’s complete analysis of GTS stock.
This week, Fresenius Medical Care AG & Co. KGaA Sponsored ADR (FMS) pushes up from a C to a B rating. Fresenius Medical Care offers kidney dialysis services and manufactures and distributes equipment and products used in the treatment of dialysis patients. Shares of the stock have been changing hands at an unusually rapid pace, three times the rate of the week prior. For more information, get Portfolio Grader’s complete analysis of FMS stock.
Bio-Reference Laboratories, Inc. (BRLI) is progressing from last week’s rating of B (“buy”) as the company improves to an A (“strong buy”) this week. Bio-Reference provides laboratory testing services, primarily to customers in the greater New York metropolitan area. For more information, get Portfolio Grader’s complete analysis of BRLI stock.
DaVita HealthCare Partners Inc. (DVA) improves from a C to a B rating this week. DaVita operates kidney dialysis centers in the United States. For more information, get Portfolio Grader’s complete analysis of DVA stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
